Your browser doesn't support javascript.
loading
Breaking the circulus vitiosus of neuroinflammation: Resveratrol attenuates the human glial cell response to cytokines.
Schlotterose, Luise; Cossais, François; Lucius, Ralph; Hattermann, Kirsten.
Afiliação
  • Schlotterose L; Institute of Anatomy, Kiel University, 24118 Kiel, Germany.
  • Cossais F; Institute of Anatomy, Kiel University, 24118 Kiel, Germany.
  • Lucius R; Institute of Anatomy, Kiel University, 24118 Kiel, Germany.
  • Hattermann K; Institute of Anatomy, Kiel University, 24118 Kiel, Germany. Electronic address: k.hattermann@anat.uni-kiel.de.
Biomed Pharmacother ; 163: 114814, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37148859
ABSTRACT
Neuroinflammation is both cause and effect of many neurodegenerative disorders. Activation of astrocytes and microglia leads to the release of cytokines and reactive oxygen species followed by blood-brain barrier leakage and neurotoxicity. Transient neuroinflammation is considered to be largely protective, however, chronic neuroinflammation contributes to the pathology of Alzheimer's disease, multiple sclerosis, traumatic brain injury, and many more. In this study, we focus on the aspect of cytokine-induced neuroinflammation in human microglia and astrocytes. Here we show by mRNA and protein analysis that cytokines, released not only by microglia but also by astrocytes, lead to a circuit of proinflammatory activation. Moreover, we present how the natural compound resveratrol can stop the circuit of proinflammatory activation and facilitate return to resting conditions. These results will contribute to distinguishing between the causes and the effects of neuroinflammation, a better understanding of underlying mechanisms, and potential treatment options.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citocinas / Doenças Neuroinflamatórias Limite: Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Citocinas / Doenças Neuroinflamatórias Limite: Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha